Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,272 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04418115 | Fatigue As a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option? | completed | N/A | 223 | Kristiania University CollegeOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT01958021 | Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer(MONALEESA-2) | completed | Phase 3 | 668 | Novartis PharmaceuticalsINDUSTRY | 29 | Mar 7, 2025 |
| NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer(NEEDS) | recruiting | Phase 3 | 1,020 | Karolinska University HospitalOTHER | 5 | Mar 6, 2025 | clinicaltrials |
| NCT05236647 | Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients(SIM) | completed | Phase 3 | 60 | University Hospital, AkershusOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT03847480 | Dose Painting of Head and Neck Cancer(RADPAINT) | completed | N/A | 7 | Oslo University HospitalOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT05243342 | A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma | completed | Phase 1 | 18 | Genentech, Inc.INDUSTRY | 4 | Feb 17, 2025 | clinicaltrials |
| NCT04731558 | Pre- Vs Postoperative Thromboprophylaxis for Liver Resection(PREPOSTEROUS) | recruiting | Phase 4 | 1,012 | Helsinki University Central HospitalOTHER | 2 | Feb 14, 2025 | clinicaltrials |
| NCT05245877 | Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery(PREPOSTEROUS2) | recruiting | Phase 4 | 800 | Helsinki University Central HospitalOTHER | 3 | Feb 14, 2025 | clinicaltrials |
| NCT03760588 | Prevention of Cardiac Dysfunction During Breast Cancer Therapy(PRADAII) | completed | Phase 2 | 138 | Torbjorn OmlandOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04903899 | 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma(LuDO-N) | recruiting | Phase 2 | 24 | Jakob StenmanOTHER | 5 | Feb 11, 2025 | clinicaltrials |
| NCT03662659 | An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers | completed | Phase 2 | 274 | Bristol-Myers SquibbINDUSTRY | 17 | Feb 5, 2025 | clinicaltrials |
| NCT01855750 | A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma | completed | Phase 3 | 838 | Janssen Research & Development, LLCINDUSTRY | 27 | Feb 4, 2025 | clinicaltrials |
| NCT03944772 | Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)(ORCHARD) | active not recruiting | Phase 2 | 247 | AstraZenecaINDUSTRY | 9 | Jan 30, 2025 | clinicaltrials |
| NCT06000046 | PROVIZ - a Machine Learning Software, to Support Targeting of Prostate Biopsies on MR Images in Biopsy-naive Patients | completed | N/A | 82 | Norwegian University of Science and TechnologyOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06529302 | The OPBC-07/microNAC Study | active not recruiting | — | 2,000 | University Hospital, Basel, SwitzerlandOTHER | 30 | Jan 24, 2025 | clinicaltrials |
| NCT04275713 | Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC(METOXY-LACC) | completed | Phase 2 | 41 | Oslo University HospitalOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT02990338 | Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients(ICARIA-MM) | completed | Phase 3 | 307 | SanofiINDUSTRY | 24 | Jan 17, 2025 | clinicaltrials |
| NCT01828099 | LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer | completed | Phase 3 | 376 | Novartis PharmaceuticalsINDUSTRY | 29 | Jan 16, 2025 | clinicaltrials |
| NCT02872259 | BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib in Metastatic Melanoma | completed | Phase 1 / Phase 2 | 74 | Haukeland University HospitalOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT04382664 | UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma | completed | Phase 2 | 156 | Ultimovacs ASAINDUSTRY | 4 | Jan 14, 2025 | clinicaltrials |
| NCT06398613 | Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)(PrePSMA) | recruiting | N/A | 600 | Oslo University HospitalOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT02488408 | A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS | completed | Phase 1 / Phase 2 | 122 | BerGenBio ASAINDUSTRY | 4 | Dec 19, 2024 | clinicaltrials |
| NCT05477589 | Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML(SCRIPT-AML) | recruiting | Phase 3 | 170 | Vastra Gotaland RegionOTHER_GOV | 10 | Dec 19, 2024 | clinicaltrials |
| NCT06740097 | Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery(ATM GBM INT) | recruiting | N/A | 50 | Kuopio University HospitalOTHER | 2 | Dec 18, 2024 | clinicaltrials |
| NCT01658930 | Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer(SHAPE) | completed | N/A | 700 | Canadian Cancer Trials GroupNETWORK | 11 | Dec 17, 2024 | clinicaltrials |
| NCT02921581 | ReIrradiation With FDG-PET Guided Dose Painting(RIDPAINT) | completed | N/A | 10 | Oslo University HospitalOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT04027309 | A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy(HOVON 156 AML) | active not recruiting | Phase 3 | 777 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 13 | Dec 17, 2024 | clinicaltrials |
| NCT04910308 | RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck(RADPAINT-2) | active not recruiting | N/A | 10 | Oslo University HospitalOTHER | 1 | Dec 17, 2024 | clinicaltrials |
| NCT01784913 | A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer(UV1/hTERT2012P) | completed | Phase 1 / Phase 2 | 22 | Ultimovacs ASAINDUSTRY | 1 | Dec 16, 2024 | clinicaltrials |
| NCT01789099 | A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.(UV1-hTERT2012L) | completed | Phase 1 / Phase 2 | 18 | Ultimovacs ASAINDUSTRY | 1 | Dec 16, 2024 | clinicaltrials |
| NCT02275416 | Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma | completed | Phase 1 / Phase 2 | 12 | Ultimovacs ASAINDUSTRY | 1 | Dec 16, 2024 | clinicaltrials |
| NCT04260269 | Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study(CardioSwitch) | enrolling by invitation | — | 200 | Helsinki University Central HospitalOTHER | 7 | Dec 12, 2024 | clinicaltrials |
| NCT03569241 | PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases(STORM) | active not recruiting | Phase 2 | 196 | University Hospital, GhentOTHER | 6 | Dec 9, 2024 | clinicaltrials |
| NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | active not recruiting | Phase 2 / Phase 3 | 140 | Oslo University HospitalOTHER | 4 | Nov 20, 2024 | clinicaltrials |
| NCT04423731 | Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2) | active not recruiting | — | 251 | Oslo University HospitalOTHER | 1 | Nov 20, 2024 | clinicaltrials |
| NCT02181413 | A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant | completed | Phase 3 | 656 | TakedaINDUSTRY | 33 | Nov 19, 2024 | clinicaltrials |
| NCT06044623 | Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients(IMPORTANT) | recruiting | Phase 3 | 495 | Region Örebro CountyOTHER | 6 | Nov 19, 2024 | clinicaltrials |
| NCT06693102 | Digital Intervention Targeting Cancer-related Cognitive Impairments | not yet recruiting | N/A | 60 | Haukeland University HospitalOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT04298112 | PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment | completed | — | 300 | Norwegian University of Science and TechnologyOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT04790968 | Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients | completed | N/A | 90 | Norwegian University of Science and TechnologyOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT04840186 | EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden(EXCALIBUR3) | suspended | Phase 2 | 62 | Oslo University HospitalOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT04898504 | HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.(EXCALIBUR1+2) | active not recruiting | Phase 2 | 45 | Oslo University HospitalOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT04127110 | Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients(ALKALINE) | active not recruiting | Phase 2 | 68 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Nov 5, 2024 | clinicaltrials |
| NCT05498623 | MR Fingerprinting for Diagnostic of Prostate Cancer | completed | — | 203 | Norwegian University of Science and TechnologyOTHER | 1 | Nov 1, 2024 | clinicaltrials |
| NCT03346889 | Vestibular Outcomes in Vestibular Schwannoma(VOVS) | active not recruiting | — | 155 | Haukeland University HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT03378297 | IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC(IMPACT) | completed | Early Phase 1 | 26 | Haukeland University HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT01436656 | A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma | completed | Phase 1 | 107 | PfizerINDUSTRY | 7 | Oct 28, 2024 | clinicaltrials |
| NCT06651151 | NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma(NeoLIPA) | recruiting | Phase 2 | 27 | Oslo University HospitalOTHER | 1 | Oct 26, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials